Thomas A. Ciulla, MD, MBA, recalls a period during training at Harvard Medical School in which the application of lasers was standard treatment for exudative age-related macular degeneration (AMD), despite its limited therapeutic effect and often costly benefit.
Describing a certain patient's situation that was marked by especially challenging circumstances, Dr Ciulla extols the arrival of anti-VEGF therapies, which in this case resulted not only in halting the disease course, but in a partial restoration of lost vision. Looking ahead, Dr. Ciulla notes that there is an enduring need for improved modes of treatment to ensure the kind of continuous care that will secure the best outcomes for patients.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Exudative Age-Related Macular Degeneration: The Advent of Anti-VEGF Agents - Medscape - Sep 18, 2023.
Comments